Wikidata

(Q42474675)

English

Nimotuzumab with chemoradiation confers a survival advantage in treatment-naïve head and neck tumors over expressing EGFR.

scientific article published on October 2010

In more languages

Statements

title
Nimotuzumab with chemoradiation confers a survival advantage in treatment-naïve head and neck tumors over expressing EGFR. (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
20647773
retrieved
1 November 2017
author name string
Chetana Basavaraj
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
20647773
retrieved
1 November 2017
Patricia Sierra
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
20647773
retrieved
1 November 2017
Jatteppanavar Shivu
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
20647773
retrieved
1 November 2017
Ramakrishnan Melarkode
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
20647773
retrieved
1 November 2017
Enrique Montero
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
20647773
retrieved
1 November 2017
Pradip Nair
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
20647773
retrieved
1 November 2017
publication date
1 October 2010
1 reference
stated in
Europe PubMed Central
PubMed ID
20647773
retrieved
1 November 2017
page(s)
673-681
1 reference
stated in
Europe PubMed Central
PubMed ID
20647773
retrieved
1 November 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q42474675&oldid=1571208671"